Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT03763760 Completed - Chronic Pain Clinical Trials

High-Dose Steroid for Hip Arthroplasty Patients Expected to Have Postoperative Pain

Start date: January 29, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the Study is to test a higher dose of steroids(Dexamethasone) given just prior to surgery in the setting of Fast-Track Hip-surgery with Arthroplasty in a group of expected High Pain Responders and the effect on postoperative pain and postoperative inflammation.

NCT ID: NCT03763734 Completed - Chronic Pain Clinical Trials

High-Dose Steroid for Knee Arthroplasty Patients Expected to Have Postoperative Pain

Start date: January 29, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the Study is to test a higher dose of steroids(Dexamethasone) given just prior to surgery in the setting of Fast-Track Knee surgery with Arthroplasty in a group of expected High Pain Responders and the effect on postoperative pain and postoperative inflammation.

NCT ID: NCT03758170 Completed - Surgery Clinical Trials

High-Dose Steroid for Knee Arthroplasty

Start date: January 29, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the Study is to test a higher dose of steroids(Dexamethasone) given just prior to surgery in the setting of Fast-Track Kneesurgery with Arthroplasty and the effect on postoperative pain and postoperative inflammation.

NCT ID: NCT03740672 Recruiting - Gynecologic Cancer Clinical Trials

Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline

Start date: November 22, 2018
Phase:
Study type: Observational

This study aims to investigate the adherence to the antiemesis NCCN guideline in Chinese patients of gynecologic malignancies, who are given chemotherapy treatment. The risk of chemotherapy induced nausea and vomiting (CINV) is calculated by the questionnaire supported by the website "CINV Risk Assessment" (http://www.riskcinv.org/).

NCT ID: NCT03712891 Active, not recruiting - Clinical trials for Patient Satisfaction

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Start date: October 25, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

NCT ID: NCT03705312 Recruiting - Heart Failure Clinical Trials

MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR

EVOLVE-MR
Start date: February 22, 2019
Phase: N/A
Study type: Interventional

This study evaluates the addition of transcatheter mitral valve repair with the MitraClip device to medical treatment in patients with heart failure and moderate functional mitral regurgitation to determine the impact of left ventricular remodelling and patients' functional capacity.

NCT ID: NCT03705026 Completed - Breast Neoplasms Clinical Trials

Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population

Start date: September 1, 2013
Phase:
Study type: Observational

Postoperative nausea and vomiting ( PONV ) is one of the common complications after general anesthesia while genetic factors may play an important role in Postoperative nausea and vomiting. In this study, the investigators investigated the relationship between gene polymorphism ( such as single nucleotide polymorphism ) of the gene HTR3A ( 5-hydroxytryptamine receptor 3A ), HTR3B ( 5-hydroxytryptamine receptor 3B ), HTR3C ( 5-hydroxytryptamine receptor 3C ) and TACR1 ( tachykinin receptor 1 ) etc. with nausea and vomiting after general anesthesia. Simultaneously, the investigators explored the influencing factors of nausea and vomiting.

NCT ID: NCT03701919 Completed - Clinical trials for Postoperative Nausea and Vomiting

Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy

Start date: January 7, 2019
Phase: Phase 4
Study type: Interventional

A common problem following sleeve gastrectomy surgery is called postoperative nausea and vomiting (PONV). This problem is uncomfortable for patients, and can also lead to other complications, including pneumonia. It is unclear what exactly causes this problem, but it may be partly caused by slow emptying of the stomach. The current treatments for PONV include medications, but these may only treat the symptoms. Botulinum toxin (BTX, brand name Botox®), produced naturally by the bacterium Clostridium botulinum and adapted for medical use, is an neurotransmitter inhibitor of the neuromuscular junction, and produces temporary muscular paralysis. BTX is widely used in cosmetic and other medical applications. Injecting BTX into the pylorus, which is the circular sphincter muscle at the end of the stomach, temporarily paralyzes the muscle, leaving it wide open, and allowing stomach contents to flow through. This effect lasts for several weeks, and then goes away. This may help prevent PONV.

NCT ID: NCT03685032 Completed - Clinical trials for Postoperative Nausea and Vomiting

Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery

Start date: August 7, 2014
Phase: N/A
Study type: Interventional

Postoperative nausea and vomiting (PONV) is a common problem and may lead to catastrophic complications, especially in neurosurgical cases. The aim of this study was to evaluate the effects of dexamethasone and ondansetron for preventing PONV in patients who underwent microvascular decompression surgery (MVD).

NCT ID: NCT03681574 Completed - Anesthesia Clinical Trials

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

This study is a clinical trial, prospective, randomized and double-blinded. Placebo, Gabapentin syrup at 15 mg/kg, and Gabapentin syrup at 30 mg/kg were administered to reduce agitation before and after in children submitted procedures (myelogram or lumbar puncture) among 1 and 6 years.